OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
原文标题
OpenAI acquires Orchestra Bio
引用来源
OpenAI
本地存档
未存档
引用格式
OpenAI. OpenAI acquires Orchestra Bio. 2026-10-20. https://www.ai007.site/news/100963
本文内容由 ai007 从公开渠道聚合,版权归原作者所有。若原文已删除或变更, 以原文站为准;本站存档仅为便于查阅而保留。